Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Genetically-altered adult stem cells can help in wound healing and are becoming crucial in regenerative medicine and drug design.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Orf infections can happen during the Muslim event 'Aid el Kebir' due to close contact with sheep.

A woman developed a severe skin reaction from the antibiotic cefalexin.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Skin symptoms are important for diagnosing infections in children.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Ultrasound can help deliver genes to cells to stimulate tissue regeneration and enhance hair growth, but more research is needed to perfect the method.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Hair follicles help attract immune cells to the skin during stress.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.